IRIS
PREVITI, Santo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.201
NA - Nord America 887
AS - Asia 231
AF - Africa 10
SA - Sud America 4
OC - Oceania 2
Totale 2.335
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 887
IT - Italia 341
IE - Irlanda 302
SE - Svezia 176
PL - Polonia 167
CN - Cina 110
SG - Singapore 104
AT - Austria 57
FR - Francia 49
DE - Germania 32
BE - Belgio 28
FI - Finlandia 19
GB - Regno Unito 9
IN - India 9
NL - Olanda 5
CO - Colombia 4
CZ - Repubblica Ceca 4
NG - Nigeria 4
UA - Ucraina 4
VN - Vietnam 4
DZ - Algeria 3
CH - Svizzera 2
KR - Corea 2
MD - Moldavia 2
AU - Australia 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TZ - Tanzania 1
Totale 2.335
Salva come PNG Salva come JPEG
Città #
Dublin 302
Chandler 255
Warsaw 166
Nyköping 152
Messina 120
Singapore 83
Ashburn 63
Vienna 57
Beijing 54
Princeton 50
Ann Arbor 38
Medford 34
Des Moines 30
Aversa 19
Jacksonville 18
Brussels 16
Dearborn 16
Montpellier 16
Cambridge 14
Modica 14
San Mateo 12
Jinan 9
Bari 8
Catania 8
Ixelles-Elsene 8
Rome 8
Houston 7
Santa Clara 7
Siderno 7
Wilmington 7
Berlin 6
Francavilla di Sicilia 6
Haikou 6
Helsinki 6
Shenyang 6
Taizhou 6
Boardman 5
Francofonte 5
Los Angeles 5
Riposto 5
Southampton 5
Borghetto Santo Spirito 4
Brno 4
Cagliari 4
Dong Ket 4
Medellín 4
Munich 4
New Delhi 4
Zhengzhou 4
Caltagirone 3
Falls Church 3
Fontaniva 3
Fuzhou 3
Hangzhou 3
Hebei 3
Hyderabad 3
Irpin 3
Lanzhou 3
Lentini 3
Milan 3
Patti 3
Rosarno 3
Seattle 3
Amsterdam 2
Avola 2
Brussel 2
Clifton 2
Dongguan 2
Ferrara 2
Hanover 2
Katsina 2
Lagos 2
Mazzarino 2
Milazzo 2
Nanjing 2
Orsay 2
Pessac 2
Piazza Armerina 2
Redmond 2
Redwood City 2
Riva 2
Saint-denis 2
Siracusa 2
Tianjin 2
Turin 2
Zurich 2
Aci Sant'Antonio 1
Aci Sant'antonio 1
Augusta 1
Bordeaux 1
Cardiff 1
Chengdu 1
Chisinau 1
Christchurch 1
Cupertino 1
Den Haag 1
Dijon 1
Floridia 1
Gravina di Catania 1
Guangzhou 1
Totale 1.793
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of novel inhibitors of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense, as antitrypanosomal agents 255
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 87
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 86
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 81
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 76
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 76
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 74
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 69
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 68
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 64
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 61
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 61
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 58
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 56
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 56
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 55
Design, synthesis and biological evaluation of potent rhodesain inhibitors as antitrypanosomal agents 55
Evaluation of curcumin irreversibility 55
Development of novel amides as non covalent inhibitors of immunoproteasome 52
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 52
Neurotensin, a multi-faceted peptide 51
null 50
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 48
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 48
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 47
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 47
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 43
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 42
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 41
Optimization of radiopharmaceuticals based on neurotensin[8-13] for NTS1-positive tumours imaging 37
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 35
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 32
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 31
Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia 31
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 30
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 29
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 29
null 27
Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents 25
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 24
Silicon-containing neurotensin analogues as radiopharmaceuticals for NTS1-positive tumors imaging 23
Optimized opioid-neurotensin multitarget peptides: from design to structure−activity relationship studies 23
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 21
null 21
null 21
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 21
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 20
Structure-based design of melanocortin 4 receptor ligands based on the SHU-9119-hMC4R cocrystal structure 20
Design, synthesis, and biological evaluation of the first radio-metalated neurotensin analogue targeting neurotensin receptor 2 20
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 17
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 17
Monoclonal antibodies: the greatest resource to treat multiple myeloma 16
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 16
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 14
Identification of dual inhibitors targeting main protease (Mpro) and cathepsin L as potential anti-SARS-CoV‑2 agents 13
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 13
null 11
The inhibition of NS2B/NS3 protease: a new therapeutic opportunity to treat Dengue and Zika virus infection 10
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia 9
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management 7
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 6
Design and synthesis of opioid-neurotensin hybrid peptidomimetics: analgesics with reduced side effect profiles 5
Design, synthesis, and in vitro characterization of proteolytically-stable opioid-neurotensin hybrid peptidomimetics 4
Supplement: 37th European Peptide Symposium 14th International Peptide Symposium August 25–August 29, 2024 | Florence, Italy 2
Hybrid synthetic approach and biological characterization of a branched heterodimer for overcoming prostate cancer heterogeneity 2
Totale 2.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 9 31 29 18 8 59 28 12
2020/2021268 15 15 50 9 37 30 14 11 49 23 8 7
2021/2022295 6 30 3 23 9 7 44 8 3 20 20 122
2022/2023997 63 97 43 78 55 105 47 79 369 4 50 7
2023/2024326 43 47 18 61 45 11 7 6 4 29 37 18
2024/2025187 30 11 23 94 29 0 0 0 0 0 0 0
Totale 2.596